228 related articles for article (PubMed ID: 31473907)
1. A psychometric analysis and revalidation of the Yale-Brown Obsessive Compulsive Scale modified for Binge Eating in adults with binge eating disorder.
Yee K; Serrano D; Kando J; McElroy SL
Qual Life Res; 2019 Dec; 28(12):3385-3394. PubMed ID: 31473907
[TBL] [Abstract][Full Text] [Related]
2. Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double-blind, placebo-controlled trials in adults with binge-eating disorder.
McElroy SL; Hudson JI; Gasior M; Herman BK; Radewonuk J; Wilfley D; Busner J
Int J Eat Disord; 2017 Aug; 50(8):884-892. PubMed ID: 28481434
[TBL] [Abstract][Full Text] [Related]
3. Lisdexamfetamine Dimesylate Effects on Binge Eating Behaviour and Obsessive-Compulsive and Impulsive Features in Adults with Binge Eating Disorder.
McElroy SL; Mitchell JE; Wilfley D; Gasior M; Ferreira-Cornwell MC; McKay M; Wang J; Whitaker T; Hudson JI
Eur Eat Disord Rev; 2016 May; 24(3):223-31. PubMed ID: 26621156
[TBL] [Abstract][Full Text] [Related]
4. Validation of the yale-brown obsessive compulsive scale modified for binge eating.
Deal LS; Wirth RJ; Gasior M; Herman BK; McElroy SL
Int J Eat Disord; 2015 Nov; 48(7):994-1004. PubMed ID: 26032442
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics and Treatment Response to Lisdexamfetamine Dimesylate Versus Placebo in Adults With Binge Eating Disorder: Analysis by Gender and Age.
Kornstein SG; Bliss C; Kando J; Madhoo M
J Clin Psychiatry; 2019 Feb; 80(2):. PubMed ID: 30817099
[TBL] [Abstract][Full Text] [Related]
6. Relationships between clinical scales and binge eating days in adults with moderate to severe binge eating disorder in two Phase III studies.
Citrome L; Kando JC; Bliss C
Neuropsychiatr Dis Treat; 2018; 14():537-546. PubMed ID: 29497297
[TBL] [Abstract][Full Text] [Related]
7. Further psychometric properties of the Yale-Brown Obsessive Compulsive Scale - Second Edition.
Wu MS; McGuire JF; Horng B; Storch EA
Compr Psychiatry; 2016 Apr; 66():96-103. PubMed ID: 26995242
[TBL] [Abstract][Full Text] [Related]
8. Lisdexamfetamine dimesylate in binge eating disorder: a placebo controlled trial.
Guerdjikova AI; Mori N; Blom TJ; Keck PE; Williams SL; Welge JA; McElroy SL
Hum Psychopharmacol; 2016 Sep; 31(5):382-91. PubMed ID: 27650406
[TBL] [Abstract][Full Text] [Related]
9. Evaluating functional disability in clinical trials of lisdexamfetamine dimesylate in binge eating disorder using the Sheehan Disability Scale.
Yee KS; Pokrzywinski R; Hareendran A; Shaffer S; Sheehan DV
Int J Methods Psychiatr Res; 2021 Mar; 30(1):e1849. PubMed ID: 32841462
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial.
Hudson JI; McElroy SL; Ferreira-Cornwell MC; Radewonuk J; Gasior M
JAMA Psychiatry; 2017 Sep; 74(9):903-910. PubMed ID: 28700805
[TBL] [Abstract][Full Text] [Related]
11. Development and psychometric evaluation of the Yale-Brown Obsessive-Compulsive Scale--Second Edition.
Storch EA; Rasmussen SA; Price LH; Larson MJ; Murphy TK; Goodman WK
Psychol Assess; 2010 Jun; 22(2):223-32. PubMed ID: 20528050
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Italian version of the Yale-Brown Obsessive Compulsive Scale-Second Edition (Y-BOCS-II) in a clinical sample.
Melli G; Avallone E; Moulding R; Pinto A; Micheli E; Carraresi C
Compr Psychiatry; 2015 Jul; 60():86-92. PubMed ID: 25842194
[TBL] [Abstract][Full Text] [Related]
13. Development and psychometric evaluation of the Mandarin Chinese version of the Yale-Brown Obsessive-Compulsive Scale - Second Edition.
Zhang CC; Gong H; Zhang Y; Jin H; Yang Y; Li B; Li Y; Luo X; Liu W; Fang F; Li B; Sun B; Fletcher T; La Buissonnière-Ariza V; Goodman WK; Storch EA
Braz J Psychiatry; 2019; 41(6):494-498. PubMed ID: 30785537
[TBL] [Abstract][Full Text] [Related]
14. Psychometric analysis of the Yale-Brown Obsessive-Compulsive Scale Second Edition Symptom Checklist.
Storch EA; Larson MJ; Price LH; Rasmussen SA; Murphy TK; Goodman WK
J Anxiety Disord; 2010 Aug; 24(6):650-6. PubMed ID: 20471199
[TBL] [Abstract][Full Text] [Related]
15. Reliability and validity of the Thai self-report version of the Yale-Brown Obsessive-Compulsive Scale-Second Edition.
Hiranyatheb T; Saipanish R; Lotrakul M; Prasertchai R; Ketkaew W; Jullagate S; Udomsubpayakul U; Kusalaruk P
Neuropsychiatr Dis Treat; 2015; 11():2817-24. PubMed ID: 26604766
[TBL] [Abstract][Full Text] [Related]
16. Responsiveness and other psychometric properties of the Yale-Brown Obsessive-Compulsive Scale Severity Scale-Second Edition in a Dutch clinical sample.
Alić M; de Leeuw A; Selier J; van Megen H; Visser H
Clin Psychol Psychother; 2022 Jul; 29(4):1355-1363. PubMed ID: 35080071
[TBL] [Abstract][Full Text] [Related]
17. [Hungarian translation of the Dimensional Yale-Brown Obsessive-Compulsive Scale and our first experiences with the test].
Harsányi A; Csigó K; Demeter G; Rajnai C; Németh A; Racsmány M
Psychiatr Hung; 2009; 24(1):18-59. PubMed ID: 19542567
[TBL] [Abstract][Full Text] [Related]
18. Reliability and validity of the Thai version of the Yale-Brown Obsessive Compulsive Scale - Second Edition in clinical samples.
Hiranyatheb T; Saipanish R; Lotrakul M
Neuropsychiatr Dis Treat; 2014; 10():471-7. PubMed ID: 24648741
[TBL] [Abstract][Full Text] [Related]
19. Criterion Validity of the Yale-Brown Obsessive-Compulsive Scale Second Edition for Diagnosis of Obsessive-Compulsive Disorder in Adults.
Castro-Rodrigues P; Camacho M; Almeida S; Marinho M; Soares C; Barahona-Corrêa JB; Oliveira-Maia AJ
Front Psychiatry; 2018; 9():431. PubMed ID: 30254588
[No Abstract] [Full Text] [Related]
20. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist.
Gallant J; Storch EA; Merlo LJ; Ricketts ED; Geffken GR; Goodman WK; Murphy TK
J Anxiety Disord; 2008 Dec; 22(8):1369-76. PubMed ID: 18329843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
